14
Dec
2026

Jiangsu Yingke Biopharmaceutical Co.,Ltd

Exhibitor at CPHI Middle East 2026 stand H2.B69
About Us

Yingke Biopharmaceutical, founded in 2011 and located in Taizhou,Jiangsu Province, is a benchmark enterprise of high-end complex drug products boosted by innovation. It is dedicated to research, development, manufacturing and commercializing of complex emulsions, topical drug products, oral drug products for gastroscopy examination and innovative long-acting complex drug products. The company possesses two provincial-level research platforms. One is the Jiangsu Engineering Laboratory for Nutritional Drug Preparation Technology and the other is the Jiangsu Engineering Research Center for Special Dosage Form Preparation Technology. Additionally, it has research and development and industrializ...

Read more Show less
  • Country/Region:
    China
  • On CPHI since:
    2025
View company profile
Contact info
  • 8618052604110
  • Building 41, No.801, , Jiankang Avenue,, 225300, Taizhou City, Jiangsu Province, China
Show contact info Hide contact info
Event information
CPHI Middle East 2026
  • 14 Dec 2026 - 16 Dec 2026
  • Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
  • Visit us at stand H2.B69

Products Featured at CPHI Middle East 2026

  • Propofol Injectable Emulsion

    Product Propofol Injectable Emulsion

    Generic Drug Consistency Evaluation National Medical Insurance Class A National Essential Medicine 20 mL:0.2 g National approval number H20223914
  • Propofol Medium and Long Chain Lipid Injectable Emulsion

    Product Propofol Medium and Long Chain Lipid Injectable Emulsion

    [Strength]20 mL:0.2 g Approval Number: National approval number H20203504 The first to Pass National Consistency Evaluation
  • Oral preparation series

    Product Oral preparation series

    1. Sodium Picosulfate,Magnesium Oxide, and Anhydrous Citric Acid Oral Solution 2. Levofloxacin Oral Solution 3. Dimethicone Emulsion 4. Levocarnitine Oral Solution
  • Three-Chamber Bag Series

    Product Three-Chamber Bag Series

    1. 1440 mL Amino acids (17), Glucose (11%) and Lipid Injectable Emulsion 2. 1026 mL Amino acids (17), Glucose (19%) and Lipid Injectable Emulsion 3. 1000 mL Amino acids (15), Glucose (20%) and Lipid Injectable Emulsion (10%) 4. 1206 mL Amino acids (16), Glucose (13%) and Structural Lipid Injectabl...
  • Topical preparation series

    Product Topical preparation series

    1. Lidocaine and Prilocaine Cream 2. Amorolfine Hydrochloride Cream 3. Mupirocin Ointment 4. Amorolfine Hydrochloride Liniment 5. Fusidic Acid Cream 6. Pimecrolimus Cream 7. Lidocaine and Tetracaine Cream

Jiangsu Yingke Biological Pharmaceutical Co., Ltd Resources (1)